Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts.

Autor: Carrascosa JM; Departamento de Dermatología, Hospital Universitario Germans Trias i Pujol, Universitat Autònoma de Barcelona. IGTP Badalona, Barcelona, España. Electronic address: jmcarrascosac@hotmail.com., Vilarrasa E; Departamento de Dermatología, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, España., Belinchón I; Departamento de Dermatología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica (ISABIAL), Universidad Miguel Hernández de Elche, Alicante, España., Herranz P; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, España., Crespo J; Servicio de Gastroenterología y Hepatología, Hospital Universitario Marqués de Valdecilla. IDIVAL. Escuela de Medicina. Universidad de Cantabria, Santander, España., Guimerá F; Servicio de Dermatología y Patología, Hospital Universitario de Canarias, La Laguna, España., Olveira A; Servicio de Aparato Digestivo, Hospital Universitario La Paz, Madrid, España.
Jazyk: English; Spanish; Castilian
Zdroj: Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2023 May; Vol. 114 (5), pp. 392-401. Date of Electronic Publication: 2023 Jan 30.
DOI: 10.1016/j.ad.2023.01.004
Abstrakt: Recent years have seen concerted efforts to understand the relation between psoriasis and metabolic-associated fatty liver disease (MAFLD). Not only is MALFD diagnosed more often in patients with psoriasis, but its clinical course is also more aggressive. A common approach is therefore needed to enable early detection of liver disease coincident with psoriasis. Especially important is an analysis of risks and benefits of potentially hepatotoxic treatments. This consensus paper presents the recommendations of a group of experts in dermatology and hepatology regarding screening for MALFD as well as criteria for monitoring patients and referring them to hepatologists when liver disease is suspected.
(Copyright © 2023 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE